Project

ORIGIN

Completed · 2004 until 2008

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2004
End Date
2008
Financing
Industry
Study Design
Multicenter, international, randomized, 2x2 factorial design study
Keywords
Outcome Reduction with initial Glargine Intervention
Brief description/objective

A Multicenter, International, Randomized, 2x2 factorial Design Study to Evaluate the Effects of Lantus (Insulin Glargine) versus Standard Care, and of Omega-3 Fatty acids versus Placebo, in reducing cardiovascular Morbidity and Mortality, People with Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (IGT) and early Type 2 Diabetes mellitus :
The ORIGIN Trial (Outcome Reduction with Initial Glargine Intervention)